Institute

Back to overview
Name

Universitätsspital Bern

Address Universitätsspital Bern
Freiburgerstr. 15
3010
CH-Bern
Show all

Projects

Responsible applicant Institution of higher education Start End date Funding scheme

Characterization and physiological role of a new antithrombotic mechanism expressed by human endothelial cells cultivated on microcarriers
Haeberli André University of Berne - BE 01.01.1996 30.04.2001 Project funding (Div. I-III)

Human Cytotoxic T cell Response to Hepatitis C Virus
Cerny Andreas University of Berne - BE 01.10.1993 31.03.1998 Project funding (Div. I-III)

Fibrinogen: Molecular symmetry, binding sites and fibrin assembly
Straub Werner University of Berne - BE 01.10.1989 31.12.1992 Project funding (Div. I-III)

Wachstum und Funktion der Schilddrüse unter verschiedenen experimentellen Bedingungen.
Studer Hugo University of Berne - BE 01.04.1985 31.03.1988 Project funding (Div. I-III)

Parkinson’s disease: a model to study substance and behavioural addictions
Krack Paul University of Berne - BE 01.10.2016 31.12.2020 Project funding (Div. I-III)

The role of antiplatelet autoantibodies and antiidiotypic anti- bodies in autoimmune thrombocytopenia
Berchtold Peter University of Berne - BE 01.04.1992 30.09.1995 Project funding (Div. I-III)

Pathogenese der Heterogenität von Wachstum und Funktion in Knoten und benignen Tumoren der Schilddrüse
Studer Hugo University of Berne - BE 01.04.1991 31.03.1994 Project funding (Div. I-III)

Fibrinogen-Heterogenität und Fibrinogen-Fibrin-Umwandlung.
Straub Werner University of Berne - BE 01.10.1983 30.09.1986 Project funding (Div. I-III)

Human fibrinogen and fibrin assembly
Straub Werner University of Berne - BE 01.10.1986 30.09.1989 Project funding (Div. I-III)

Fibrinogen-Fibrin-Umwandlung und Thrombogenese: Untersuchungen mit der Lichtstreuung
Straub Werner University of Berne - BE 01.10.1976 30.09.1977 Project funding (Div. I-III)

Biologische Bedeutung der Heterogenität der B/b und g- Polypeptidketten von menschlichem Fibrinogen und Fibrin
Straub Werner University of Berne - BE 01.10.1978 30.09.1980 Project funding (Div. I-III)

Die Regulation der Schilddrüsenfunktion unter ver- schiedenen experimentellen Bedingungen
Studer Hugo University of Berne - BE 01.04.1976 31.03.1979 Project funding (Div. I-III)

Die Regulation der Schilddrüsenfunktion unter verschie- denen experimentellen Bedingungen
Studer Hugo University of Berne - BE 01.04.1982 31.03.1985 Project funding (Div. I-III)

Biologische Bedeutung der Heterogenität von Fibrinogen und Fibrin
Straub Werner University of Berne - BE 01.10.1980 30.09.1983 Project funding (Div. I-III)

A) Regulation of albumin synthesis and transcapillary escape of albumin in man / B) Regulation of hepatic protein synthesis underinflammatory conditions in the rat.
Ballmer Peter University of Berne - BE 01.11.1993 28.02.1997 Project funding (Div. I-III)

Inhibition of matrix metalloproteinases and of mesangial cell proliferation: a new approach to the therapy of glomerulonephri- tis
Marti Hans-Peter University of Berne - BE 01.04.1997 31.08.1999 Project funding (Div. I-III)

Electroporation-mediated delivery of functional genes to the failing heart
Kadner Alexander University of Berne - BE 01.01.2008 30.06.2011 Project funding (Div. I-III)

Glycocalicin - a platelet marker: Plasma levels in health and disease, structure, function and halflife
Beer Hans-Jürg University of Berne - BE 01.07.1992 30.09.1994 Project funding (Div. I-III)

Immunotargeting of Liposomes and Virosomes to Mesangial Cells: A New Strategy for Directed Drug Delivery to Treat Mesangial Proliferative Glomerulonephritis
Marti Hans-Peter University of Zurich - ZH 01.09.2003 30.09.2006 Project funding (Div. I-III)

A) Influence of nutrition and acute-phase reaction on albumin synthesis rates (ASR) in humans.B)Regulation of protein synthesis in different tissues of the rat by nutritional support and ....
Ballmer Peter University of Berne - BE 01.11.1991 31.10.1993 Project funding (Div. I-III)

Fibrinogen-Fibrin-Umwandlung und Thrombogenese: Untersuchungen mit Lichtstreuung
Straub Werner University of Berne - BE 01.01.1979 31.12.1980 Project funding (Div. I-III)

Matrix metalloproteinases in kidney diseases: antifibrotic en- zymes or proinflammatory agents?
Marti Hans-Peter University of Berne - BE 01.09.1999 28.02.2003 Project funding (Div. I-III)

Die Regulation der Schilddrüsenfunktion unter verschiedenen experimentellen Bedingungen.
Studer Hugo University of Berne - BE 01.04.1979 31.03.1982 Project funding (Div. I-III)

Wachstum und Funktion der Schilddrüse unter verschiedenen experimentellen Bedingungen
Studer Hugo University of Berne - BE 01.04.1988 31.03.1991 Project funding (Div. I-III)

Development of antithrombotic agents based on fibrinogen-derived peptides with prolonged circulation time
Straub Werner University of Berne - BE 01.01.1993 31.12.1995 Project funding (Div. I-III)

Combination of functional imaging and detailed lung function assessment to describe lung development in preterm children
Yammine Sophie University of Berne - BE 01.07.2019 30.06.2023 Ambizione

Autoimmune thrombocytopenia: generation of recombinant anti- Glycoprotein IIb-IIIa autoantibodies and antiidiotypic antibodies
Berchtold Peter University of Berne - BE 01.10.1995 30.09.1998 Project funding (Div. I-III)

The effect of macrophages and T lymphocytes on the expression of rat mesangial cell 72-kDa type IV collagenase
Marti Hans-Peter University of Berne - BE 01.06.1994 31.03.1997 Project funding (Div. I-III)

Structure and function od platelet GPIb
Beer Hans-Jürg University of Berne - BE 01.10.1994 30.09.1997 Project funding (Div. I-III)

a) Development of a sensitive sandwich-immunoassay for human pla-telet glycocalicin. b) hemorrhagic diathesis produced by rt-PA, with special focus on platelet glycoprotein IB/glycocalicin
Beer Hans-Jürg University of Berne - BE 01.07.1990 30.06.1992 Project funding (Div. I-III)

Fibrinogen-Fibrin-Umwandlung und Thrombogenese: Untersuchung mit Lichtstreuung
Straub Werner University of Berne - BE 01.10.1977 31.12.1978 Project funding (Div. I-III)
-